عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
TT
TT

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA

Saudi Arabia’s King Fahd Medical City and Boston Oncology have signed a Memorandum of Understanding (MoU) for a project to localize gene and target cell therapy.

The project will be held at King Fahd Medical City, one of the components of the Riyadh Second Health Cluster, the Saudi Press Agency (SPA) reported Monday.
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj.

The Saudi Deputy Minister for Planning and Development Eng. Abdulaziz Al-Rumaih attended the signing ceremony at the Saudi Ministry of Health.

AlGhofaili affirmed that the MoU aligns with the Medical City's plans towards the objectives of the Saudi Transformation Program in Healthcare Sector, which contributes to the enhancement of advanced healthcare services provided through the localization of modern techniques in treatment.

"The localization of therapeutic technology in the Kingdom is one of our main goals, which aligns with the Saudi Vision 2030 regarding health transformation programs,” SPA quoted AlGhofaili as saying.

“Therefore, we seek to develop local capabilities in the field of advanced medical treatment and technologies by enhancing cooperation with national and international institutions,” he added.

Most Viewed

 
 
Varieties

Saudi Northern Borders Witness Return of Diplotaxis

Photo by SPA
Photo by SPA
TT
TT

Saudi Northern Borders Witness Return of Diplotaxis

Photo by SPA
Photo by SPA

The Saudi Northern Borders region, renowned for its diverse desert landscape, is witnessing the resurgence of the Diplotaxis, a vibrant yellow-flowered species that had become increasingly rare.
This resurgence is attributed to continuous conservation efforts, including the establishment of wildlife reserves and the implementation of stricter environmental protection laws, according to SPA.
Diplotaxis is an annual plant in the Northern Boreders region, typically reaching half a meter in height. Its hairy leaves, an adaptation to the harsh desert climate, help retain moisture. The plant thrives in gravelly soils and blooms in spring with fragrant yellow flowers.
Aman Environmental Association Board of Directors Chairman Nasser Al-Majlad told SPA that the early rainfall this year fostered the growth of numerous plant species, including Diplotaxis, which had been absent from the area for several years.
The Northern Borders region boasts a rich variety of plant life, including aromatic, seasonal, and annual species.

This diverse flora plays a crucial role in combating desertification, stabilizing soil, increasing biodiversity, and enhancing the region's environmental health. Moreover, it contributes to the region's tourism appeal.